Session date: 
Wednesday, January 27, 2016 - 9:00am to 10:00am
Location: 
ISTH Webinar Library Once a Month
Carrboro, NC 27510
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.
Program Description: 

Through its educational arm, the ISTH Academy, the International Society on Thrombosis and Haemostasis (ISTH) has begun hosting a series of webinars on practical thrombosis and haemostasis issues that scientists and physicians frequently confront. These webinars will allot time for participants to ask questions and will cover the latest information on relevant topics.

Speakers:

Adam Cuker - "Monitoring unfractionated heparin: best practices and controversies"
Dr. Cuker willreview evidence, controversies, and best practices in the measurement and monitoring of unfractionated heparin, low molecular weight heparin, and fondaparinux.

Gualtiero Palareti - "Monitoring of direct oral anticoagulants"
Dr. Palareti will review in which circumstances and for which purposes measuring the concentration of the direct oral anticoagulants (DOACs) is indicated and which are the laboratory assays that should be used for this scope and those that are not recommended.

Moderator: Geoff Barnes

Biographies

Adam Cuker

Dr. Cuker is Assistant Professor of Medicine and Pathology & Laboratory Medicine at the University of Pennsylvania. He received his M.D. from Yale University and completed an internship and residency in internal medicine at Brigham and Women’s Hospital and Harvard Medical School. He continued his postgraduate training at the Hospital of the University of Pennsylvania where he was a fellow in hematology/oncology. He holds a Master’s degree in Translational Research from the University of Pennsylvania. He is Director of the Penn Comprehensive Hemophilia & Thrombosis Program, Clinical Director of the Penn Blood Disorders Center, and Associate Director for Clinical Research of the Penn-CHOP Blood Center for Patient Care and Discovery. Major focuses of his research include laboratory measurement of anticoagulation, heparin-induced thrombocytopenia, and immune thrombocytopenia. He is Chair of the forthcoming American Society of Hematology guidelines on venous thromboembolism; serves on the Board of Directors of the Hemostasis & Thrombosis Research Society and the Anticoagulation Forum; is a fellow of the American College of Physicians; and a member of ISTH.

Gualtiero Palareti

Dr. Palareti is a Professor of Cardiovascular Diseases at the University of Bologna, Italy. He is a co-Founder and former President of the Italian Federation of Anticoagulation Clinics (FCSA). From 2004-2012 he served as aCo-Chairman of the SSC Scientific Subcommittee on Control of Anticoagulation of the International Society on Thrombosis and Haemostasis (ISTH). He is also a former President of theItalian Society for Hemostasis and Thrombosis (SISET).

Geoff Barnes

Dr. Barnes is a cardiologist and vascular medicine specialist at the University of Michigan in Ann Arbor, Michigan, USA. His research interests include quality improvement in anticoagulation and the used of shared decision making tools for venous thromboembolism. He currently serves as the immediate past chair of the ISTH Young Professional Task Force and serves on the ISTH Education committee.

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Medical College of Wisconsin and International Society on Thrombosis and Haemostasis. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
 
Designation of Credit Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
More information and online registration:  http://www.prolibraries.com/isth/
 

Sponsored by an unrestricted educational grant from:  Instrumentation Laboratory


 
Target audience: 

Clinicaians and laboratory professional involved in the management of patients on anticoagulant therapy

Learning objectives: 

At the conclusion of this activity, I will be able to:

  • Understand the evidence for and against laboratory monitoring of unfractionated heparin.
  • Identify indications for measurement of low molecular weight heparin and fondaparinux.
  • Describe current best practices for monitoring and measurement of unfractionated heparin, low molecular weight heparin, and fondaparinux.
  • Understand the difference between monitoring and measuring anticoagulant agents
  • Learn in which circumstances measuring the concentration of DOACs can help clinical management decisions
  • Understand which are the assays that are recommended to measure the effect of dabigatran, rivaroxaban, apixaban and edoxaban
  • Understand which are the limitations of routine coagulation assays for this scope and why their use is not recommended to measure the anticoagulant effect of DOACs
  • Understand which are the specific effects of DOACs on tests of hemostasis
Faculty & credentials: 
Planning Committee:
Geoffrey Barnes, MD
Chris Ward, PhD
Stephen Watson, PhD
 
 
Speakers:
Adam Cuker "Laboratory Measurement of the Heparin-based agents"

Dr. Adam Cuker will review evidence, controversies, and best practices in the measurement and monitoring of unfractionated heparin, low molecular weight heparin, and fondaparinux.

Gualtiero Palareti "Monitoring of direct oral anticoagulants"

Dr. Gualtiero Palareti will review in which circumstances and for which purposes measuring the concentration of the direct oral anticoagulants (DOACs) is indicated and which are the laboratory assays that should be used for this scope and those that are not recommended.

Moderator:

Geoff Barnes

All persons in control of content have NO relevant financial relationships to disclose with the exception of the following persons:  
 

Name

Company

Role

Geoffrey Barnes, MDPortolaConsulting
 Blue Cross Blue Shield of MichiganResearch
 BMS/PfizerResearch
Chris Ward, PhDBayerSpeaker
 Boehringer-IngelheimSpeaker, Advisory Board
 BMS/PfizerSpeaker, Advisory Board
Adam Cuker, MDAmgenConsultant
 GenzymeConsultant
 Bracco Diagnostic ImagingConsultant
Gualtiero Palareti, MDAlfa-WassermannAdvisory Board
 Daiichi-SankyoAdvisory Board
 Instrumentation Laboratory/WerfenSpeaker
 SiemensSpeaker
 StagoSpeaker

In accordance with the ACCME®  Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved

CME Coordinator Contact Information

Name: 
Lacey Schmeidler, MA
Phone number: 
+1 (919) 929-3807